Advertisement

Klinische Wochenschrift

, Volume 65, Issue 20, pp 949–954 | Cite as

Insulin receptor binding to blood cells: An outdated concept for clinical studies on insulin resistance?

  • M. J. Müller
Übersicht

Summary

Clinical data on insulin binding to blood cells contribute to our present knowledge of insulin resistance. Binding data have been frequently presented to indicate alterations in insulin action. It is now evident that insulin binding data are of limited value for our understanding of insulin resistance. This is mainly due to the tissue-specific binding of insulin as well as the “pleiotypic” nature of insulin action. As insulin action is determined at (a) the “pre-”receptor level, (b) the receptor, and/or (c) different postbinding sites, it is unlikely that receptor data alone can explain defective insulin action. As knowledge of the molecular biology of insulin receptor morphology and function as well as of the action of insulin on intermediary metabolism increases, clinicians should not be further overloaded with binding data. Nevertheless, binding data on blood cells may be still of some value in investigating patients with severe insulin resistance due to genetic disorders of the insulin receptor or insulin receptor autoantibodies.

Key words

Insulin receptor Insulin resistance Insulin action 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ardawi MJM, Newsholme EA (1985) Metabolism of lymphocytes and its importance in the immune response. Essays Biochem 21:1–44Google Scholar
  2. 2.
    Arner P, Einarsson K, Bachman L, Nilsell L, Lerea KM, Livingston JN (1983) Studies of liver insulin receptors in non-obese and obese human subjects. J Clin Invest 72:1729–1736Google Scholar
  3. 3.
    Arner P, Bolinder J, Wennlund A, Oestman J (1984) Influence of thyroid hormone level on insulin action in human adipose tissue. Diabetes 33:369–375Google Scholar
  4. 4.
    Baker B, Mandarino C, Brick B, Rizza R, Gerich J (1984) Influences of changes in insulin receptor binding during insulin infusions on the shape of the insulin dose-response curve for glucose disposal in man. J Clin Endocrin Metab 58:392–396Google Scholar
  5. 5.
    Beck-Nilson H, Pederson O (1979) Insulin binding, insulin degradation and glucose metabolism in human monocytes. Diabetologia 17:77–84Google Scholar
  6. 6.
    Björntop P, Sjöstrom L (1978) Carbohydrate storage in man: speculations and some quantitative considerations. Metabolism 27:1853–1863Google Scholar
  7. 7.
    Cheng JS, Kalant F (1970) Effect of insulin and growth hormone on the flux rates of plasma glucose and plasma free fatty acids in man. J Clin Endocrin Metab 31:647–653Google Scholar
  8. 8.
    Engfeldt P, Bolinder J, Oestman J, Arner P (1985) Effect of fasting on insulin receptor binding and insulin action in different human subcutaneous fat depots. J Clin Endocrin Metab 60:868–873Google Scholar
  9. 9.
    Ferrannini E, Douglas Smith J, Cobelli C, Toffolo G, Pilo A, DeFronzo RA (1985) Effects of insulin on the distribution and disposition of glucose in man. J Clin Invest 76:357–364Google Scholar
  10. 10.
    Foley JA, Thuillez P, Lillioja S, Zawadziki J, Bogardus C (1986) Insulin sensitivity in adipocytes from subjects with varying degrees of glucose tolerance. Am J Physiol 251:E306-E310Google Scholar
  11. 11.
    Freidenberg GR, Henry RR, Klein HH, Reichart DR, Olefsky JM (1987) Decreased kinase activity of insulin receptors from adipocytes of non-insulin dependent diabetic subjects. J Clin Invest 79:240–250Google Scholar
  12. 12.
    Garvey WT, Olefsky JM, Marshall S (1986) Insulin induces progressive insulin resistance in cultured rat adipocytes. Diabetes 35:258–267Google Scholar
  13. 13.
    Grigoresen F, Flier JS, Kahn CR (1986) Characterization of binding and phosphorylation defects of erythrocyte insulin receptors in type A syndrome of insulin resistance. Diabetes 35:127–138Google Scholar
  14. 14.
    Helderman JH (1981) Role of insulin in the intermediary metabolism of the activated thymic-derived lymphocyte. J Clin Invest 67:1636–1642Google Scholar
  15. 15.
    Helderman JH (1984) Acute regulation of human lymphocyte insulin receptors — analysis by glucose clamp. J Clin Invest 74:1428–1435Google Scholar
  16. 16.
    Houslay MD (1986) Insulin, glucagon and the receptor mediated control of cyclicAMP concentrations in the liver. Biochem Soc Transact 14:183–193Google Scholar
  17. 17.
    James DE, Jenkins AB, Kreagen EW (1985) Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. Am J Physiol 248:E567-E574Google Scholar
  18. 18.
    Kahn R (1986) Insulin resistance: a common feature of diabetes mellitus. N Engl J Med 315:252–253Google Scholar
  19. 19.
    Kashiwagi A, Bogardus C, Lillioja S, Hückstack TP, Brady D, Verso MA, Foley JE (1984) In vitro insensitivity of glucose transport and antilipolysis to insulin due to receptor and postreceptor abnormalities in obese Pima indians with normal glucose tolerance. Metabolism 33:772–777Google Scholar
  20. 20.
    Kolterman OGG, Reaven GM, Olefsky JH (1979) Relationship between in vivo insulin resistance and decrease in insulin receptors in obese man. J Clin Endocrin Metab 48:487–494Google Scholar
  21. 21.
    Mandarino LJ, Madar Z, Kolterman OL, Bell JM, Olefsky JM (1986) Adipocyte glycogen synthase and pyruvatedehydrogenase in obese and type II diabetic subjects. Am J Physiol 251:E489-E496Google Scholar
  22. 22.
    Müller MJ, von Schütz B, Huhnt HJ, Zick R, Mitzkat HJ, von zur Mühlen A (1986) Glucoregulatory function of thyroid hormones: interaction with insulin depends on the prevailing glucose concentration. J Clin Endocrin Metab 63:62–71Google Scholar
  23. 23.
    Oefelein MG, Arsenis G, Livingston JN (1986) Insulin stimulated fluid phase pinocytosis and internalization of the insulin receptor: differences between the U-937 monocyte and rat adipocyte. Metabolism 35:818–823Google Scholar
  24. 24.
    Pederson O (1983) Insulin receptor assays and human studies: merits and limitations. Diabetes Care 6:301–309Google Scholar
  25. 25.
    Prager R, Wallace P, Olefsky JM (1986) In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Investig 78:472–481Google Scholar
  26. 26.
    Randin JP, Tappy L, Scazziga B, Jequier E, Felber JP (1986) Insulin sensitivity and exogenous insulin clearance in Grave's disease. Diabetes 35:178–181Google Scholar
  27. 27.
    Simpson IA, Hedo JH (1984) Insulin receptor phosphorylation may not be a prerequisite for acute insulin action. Science 223:1301–1303Google Scholar
  28. 28.
    Taylor R (1986) Insulin receptors and the clinician. Br Med J 292:919–922Google Scholar
  29. 29.
    Ulrich A, Bell JR, Chen EY, Herrera R, Petruzelli LM, Dull TJ, Gray A, Cowan L, Liao Y-L, Tsubokawa M, Mason A, Seeberg PH, Grunfeld C, Rosen OM, Ramachandran J (1985) Human insulin receptor and its relationship to the tyrosinekinase family of oncogenes. Nature 313:756–761Google Scholar
  30. 30.
    von Schütz B, Müller MJ (1986) T3 directly decreases insulin receptor binding to cultured human T-lymphocytes. Acta Endocrinol 276 (Suppl 274):113Google Scholar
  31. 31.
    Ward GM, Harrison LC (1986) Structure of the human erythrocyte insulin receptor. Diabetes 35:101–105Google Scholar
  32. 32.
    Wennlund A, Arner P, Oestman J (1981) Changes of the effects of insulin on human adipose tissue metabolism in hyperthyroidism. J Clin Endocrin Metab 53:631–635Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • M. J. Müller
    • 1
  1. 1.Medizinische Hochschule HannoverAbteilung Klinische EndokrinologieGermany

Personalised recommendations